A multicentre study of coagulation and haemostatic variables during oral contraception: variations with four formulations
- 1 November 1991
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 98 (11) , 1117-1128
- https://doi.org/10.1111/j.1471-0528.1991.tb15364.x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Hypercoagulability StatesCRC Critical Reviews in Clinical Laboratory Sciences, 1979
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- Factor VII in an Industrial PopulationBritish Journal of Haematology, 1974
- ANTITHROMBIN III AND THE ŒSTROGEN CONTENT OF COMBINED ŒSTRO-PROGESTAGEN CONTRACEPTIVESThe Lancet, 1972
- Low Fibrinolytic Activity of Veins During Treatment with Ethinylo EstradiolPublished by Wiley ,1971
- EFFECT OF COMBINED ŒSTROGEN-PROGESTOGEN ORAL CONTRACEPTIVES, ŒSTROGEN, AND PROGESTOGEN ON ANTIPLASMIN AND ANTITHROMBIN ACTIVITYThe Lancet, 1970
- The Coagulation Mechanism in Oral ContraceptionPublished by Wiley ,1967
- Effect of a progestin-estrogen oral contraceptive on blood clotting factorsMetabolism, 1965
- EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOODThe Lancet, 1964
- Oral Contraception and Blood CoagulabilityBMJ, 1963